Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 1 , Pages 1-16 , February 2008

Epigenetic regulation and fetal programming

  • Christine Gicquel, MD, PhD (Doctor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +61-3-8532-1310; Fax: +61-3-8532-1100.

References 

  1. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiological Reviews. 2005;85:571–633
  2. Gluckman PD, Hanson MA, Beedle AS. Early life events and their consequences for later disease: a life history and evolutionary perspective. American Journal of Human Biology. 2007;19:1–19
  3. Neel JV. Diabetes mellitus: a ‘thrifty’ genotype rendered detrimental by ‘progress’?. American Journal of Human Genetics. 1962;14:353–362
  4. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35:595–601
  5. Barker DJ, Hales CN, Fall CH, et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993;36:62–67
  6. Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science. 2004;305:1733–1736
  7. Bateson P, Barker D, Clutton-Brock T, et al. Developmental plasticity and human health. Nature. 2004;430:419–421
  8. Gluckman PD, Hanson MA, Spencer HG, et al. Environmental influences during development and their later consequences for health and disease: implications for the interpretation of empirical studies. Proceedings. Biological Sciences. 2005;272:671–677
  9. Gluckman PD, Hanson MA. Developmental plasticity and human disease: research directions. Journal of Internal Medicine. 2007;261:461–471
  10. Fowden AL, Giussani DA, Forhead AJ. Intrauterine programming of physiological systems: causes and consequences. Physiology (Bethesda, Md.). 2006;21:29–37
  11. Roseboom T, de Rooij S, Painter R. The Dutch famine and its long-term consequences for adult health. Early Human Development. 2006;82:485–491
  12. Fowden AL, Giussani DA, Forhead AJ. Endocrine and metabolic programming during intrauterine development. Early Human Development. 2005;81:723–734
  13. Karlberg JP, Albertsson-Wikland K, Kwan EY, et al. The timing of early postnatal catch-up growth in normal, full-term infants born short for gestational age. Hormone Research. 1997;48(Suppl 1):17–24
  14. Ong KK, Ahmed ML, Emmett PM, et al. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ (Clinical Research Ed.). 2000;320:967–971
  15. Jaquet D, Gaboriau A, Czernichow P, et al. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. The Journal of Clinical Endocrinology and Metabolism. 2000;85:1401–1406
  16. Huxley RR, Shiell AW, Law CM. The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systematic review of the literature. Journal of Hypertension. 2000;18:815–831
  17. Seckl JR. Prenatal glucocorticoids and long-term programming. European Journal of Endocrinology/European Federation of Endocrine Societies. 2004;151(Suppl 3):U49–U62
  18. Matthews SG. Early programming of the hypothalamo-pituitary-adrenal axis. Trends in Endocrinology and Metabolism. 2002;13:373–380
  19. Lesage J, Blondeau B, Grino M, et al. Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat. Endocrinology. 2001;142:1692–1702
  20. Fowden AL, Hill DJ. Intra-uterine programming of the endocrine pancreas. British Medical Bulletin. 2001;60:123–142
  21. Petrik J, Arany E, McDonald TJ, et al. Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology. 1998;139:2994–3004
  22. Boujendar S, Reusens B, Merezak S, et al. Taurine supplementation to a low protein diet during fetal and early postnatal life restores a normal proliferation and apoptosis of rat pancreatic islets. Diabetologia. 2002;45:856–866
  23. Ozanne SE, Hales CN. Early programming of glucose-insulin metabolism. Trends in Endocrinology and Metabolism. 2002;13:368–373
  24. Gicquel C, Le Bouc Y. Hormonal regulation of fetal growth. Hormone Research. 2006;65(Suppl 3):28–33
  25. Heude B, Ong KK, Luben R, et al. Study of association between common variation in the IGF2 gene and indices of obesity and body size in middle-age men and women. The Journal of Clinical Endocrinology and Metabolism. 2007;92:2734–2738
  26. Murrell A, Heeson S, Cooper WN, et al. An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype. Human Molecular Genetics. 2004;13:247–255
  27. Petry CJ, Ong KK, Wingate DL, et al. Genetic variation in the type 2 insulin-like growth factor receptor gene and disparity in childhood height. Growth Hormone & IGF Research. 2005;15:363–368
  28. Gaunt TR, Cooper JA, Miller GJ, et al. Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Human Molecular Genetics. 2001;10:1491–1501
  29. Roth SM, Schrager MA, Metter EJ, et al. IGF2 genotype and obesity in men and women across the adult age span. International Journal of Obesity and Related Metabolic Disorders. 2002;26:585–587
  30. Petry CJ, Ong KK, Barratt BJ, et al. Common polymorphism in H19 associated with birthweight and cord blood IGF-II levels in humans. BMC Genetics. 2005;6:22
  31. Fowden AL. The insulin-like growth factors and feto-placental growth. Placenta. 2003;24:803–812
  32. Arends N, Johnston L, Hokken-Koelega A, et al. Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). The Journal of Clinical Endocrinology and Metabolism. 2002;87:2720
  33. Vaessen N, Janssen JA, Heutink P, et al. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet. 2002;359:1036–1037
  34. Johnston LB, Dahlgren J, Leger J, et al. Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestational age populations. The Journal of Clinical Endocrinology and Metabolism. 2003;88:4805–4810
  35. Frayling TM, Hattersley AT, McCarthy A, et al. A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes. 2002;51:2313–2316
  36. Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet. 1999;353:1789–1792
  37. Frayling TM, Hattersley AT. The role of genetic susceptibility in the association of low birth weight with type 2 diabetes. British Medical Bulletin. 2001;60:89–101
  38. Hattersley AT, Beards F, Ballantyne E, et al. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nature Genetics. 1998;19:268–270
  39. Eriksson JG, Lindi V, Uusitupa M, et al. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth. Diabetes. 2002;51:2321–2324
  40. Dunger DB, Petry CJ, Ong KK. Genetic variations and normal fetal growth. Hormone Research. 2006;65(Suppl 3):34–40
  41. Le Stunff C, Fallin D, Schork NJ, et al. The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity. Nature Genetics. 2000;26:444–446
  42. Le Fur S, Auffray C, Letourneur F, et al. Heterogeneity of class I INS VNTR allele association with insulin secretion in obese children. Physiological Genomics. 2006;25:480–484
  43. Le Stunff C, Fallin D, Bougneres P. Paternal transmission of the very common class I INS VNTR alleles predisposes to childhood obesity. Nature Genetics. 2001;29:96–99
  44. Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition. 2004;20:63–68
  45. Feil R. Environmental and nutritional effects on the epigenetic regulation of genes. Mutation Research. 2006;600:46–57
  46. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genetics. 2003;33(Suppl):245–254
  47. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nature Reviews. Genetics. 2007;8:253–262
  48. Godfrey KM, Lillycrop KA, Burdge GC, et al. Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease. Pediatric Research. 2007;61:5R–10R
  49. Vickaryous N, Whitelaw E. The role of early embryonic environment on epigenotype and phenotype. Reproduction, Fertility, and Development. 2005;17:335–340
  50. Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457–463
  51. Reik W, Walter J. Genomic imprinting: parental influence on the genome. Nature Reviews. Genetics. 2001;2:21–32
  52. El-Osta A. Understanding the consequences of epigenetic mechanisms and its effects on transcription in health and disease. Cancer Biology & Therapy. 2004;3:816–818
  53. Wassenegger M. The role of the RNAi machinery in heterochromatin formation. Cell. 2005;122:13–16
  54. Harikrishnan KN, Chow MZ, Baker EK, et al. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nature Genetics. 2005;37:254–264
  55. Delaval K, Feil R. Epigenetic regulation of mammalian genomic imprinting. Current Opinion in Genetics & Development. 2004;14:188–195
  56. Constancia M, Hemberger M, Hughes J, et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature. 2002;417:945–948
  57. Constancia M, Angiolini E, Sandovici I, et al. Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:19219–19224
  58. Angiolini E, Fowden A, Coan P, et al. Regulation of placental efficiency for nutrient transport by imprinted genes. Placenta. 2006;27(Suppl A):S98–S102
  59. Fowden AL, Ward JW, Wooding FP, et al. Programming placental nutrient transport capacity. The Journal of Physiology. 2006;572:5–15
  60. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science. 2001;293:1089–1093
  61. Gicquel C, Rossignol S, Cabrol S, et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver–Russell syndrome. Nature Genetics. 2005;37:1003–1007
  62. Gaston V, Le Bouc Y, Soupre V, et al. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith–Wiedemann syndrome. European Journal of Human Genetics. 2001;9:409–418
  63. Poulsen P, Esteller M, Vaag A, et al. The epigenetic basis of twin discordance in age-related diseases. Pediatric Research. 2007;61:38R–42R
  64. Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:10604–10609
  65. Wong AH, Gottesman II, Petronis A. Phenotypic differences in genetically identical organisms: the epigenetic perspective. Human Molecular Genetics. 2005;14 Spec No 1:R11–R18
  66. Kant SG, van der Weij AM, Oostdijk W, et al. Monozygous triplets discordant for transient neonatal diabetes mellitus and for imprinting of the TNDM differentially methylated region. Human Genetics. 2005;117:398–401
  67. Weksberg R, Shuman C, Caluseriu O, et al. Discordant KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith–Wiedemann syndrome. Human Molecular Genetics. 2002;11:1317–1325
  68. Khosla S, Dean W, Reik W, et al. Culture of preimplantation embryos and its long-term effects on gene expression and phenotype. Human Reproduction Update. 2001;7:419–427
  69. Doherty AS, Mann MR, Tremblay KD, et al. Differential effects of culture on imprinted H19 expression in the preimplantation mouse embryo. Biology of Reproduction. 2000;62:1526–1535
  70. Khosla S, Dean W, Brown D, et al. Culture of preimplantation mouse embryos affects fetal development and the expression of imprinted genes. Biology of Reproduction. 2001;64:918–926
  71. Mann MR, Lee SS, Doherty AS, et al. Selective loss of imprinting in the placenta following preimplantation development in culture. Development. 2004;131:3727–3735
  72. Young L, Fernandes K, McEvoy T, et al. Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nature Genetics. 2001;27:153–154
  73. Gicquel C, Gaston V, Mandelbaum J, et al. In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the abnormal imprinting of the KCN1OT gene. American Journal of Human Genetics. 2003;72:1338–1341
  74. Arnaud P, Feil R. Epigenetic deregulation of genomic imprinting in human disorders and following assisted reproduction. Birth Defects Research. Part C, Embryo Today. 2005;75:81–97
  75. Rossignol S, Steunou V, Chalas C, et al. The epigenetic imprinting defect of Beckwith-Wiedemann patients born following assisted reproductive technology is not restricted to the 11p15 region. Journal of Medical Genetics. 2006;43:902–907
  76. MacLennan NK, James SJ, Melnyk S, et al. Uteroplacental insufficiency alters DNA methylation, one-carbon metabolism, and histone acetylation in IUGR rats. Physiological Genomics. 2004;18:43–50
  77. Lillycrop KA, Phillips ES, Jackson AA, et al. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. The Journal of Nutrition. 2005;135:1382–1386
  78. Lillycrop KA, Slater-Jefferies JL, Hanson MA, et al. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. The British Journal of Nutrition. 2007;97:1–10
  79. Weaver IC, Cervoni N, Champagne FA, et al. Epigenetic programming by maternal behavior. Nature Neuroscience. 2004;7:847–854
  80. Meaney MJ, Szyf M, Seckl JR. Epigenetic mechanisms of perinatal programming of hypothalamic–pituitary–adrenal function and health. Trends in Molecular Medicine. 2007;13:269–277
  81. Pham TD, MacLennan NK, Chiu CT, et al. Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2003;285:R962–R970
  82. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Molecular and Cellular Biology. 2003;23:5293–5300
  83. Dolinoy DC, Weidman JR, Waterland RA, et al. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environmental Health Perspectives. 2006;114:567–572
  84. Waterland RA, Lin JR, Smith CA, et al. Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus. Human Molecular Genetics. 2006;15:705–716
  85. Ingrosso D, Cimmino A, Perna AF, et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet. 2003;361:1693–1699
  86. Drake AJ, Walker BR. The intergenerational effects of fetal programming: non-genomic mechanisms for the inheritance of low birth weight and cardiovascular risk. The Journal of Endocrinology. 2004;180:1–16
  87. Gluckman PD, Hanson MA, Beedle AS. Non-genomic transgenerational inheritance of disease risk. Bioessays. 2007;29:145–154
  88. Stewart RJ, Preece RF, Sheppard HG. Twelve generations of marginal protein deficiency. The British Journal of Nutrition. 1975;33:233–253
  89. Drake AJ, Walker BR, Seckl JR. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2005;288:R34–R38
  90. Chong S, Whitelaw E. Epigenetic germline inheritance. Current Opinion in Genetics & Development. 2004;14:692–696
  91. Morgan HD, Sutherland HG, Martin DI, et al. Epigenetic inheritance at the agouti locus in the mouse. Nature Genetics. 1999;23:314–318
  92. Lane N, Dean W, Erhardt S, et al. Resistance of IAPs to methylation reprogramming may provide a mechanism for epigenetic inheritance in the mouse. Genesis. 2003;35:88–93
  93. Anway MD, Cupp AS, Uzumcu M, et al. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science. 2005;308:1466–1469
  94. Chong S, Youngson NA, Whitelaw E. Heritable germline epimutation is not the same as transgenerational epigenetic inheritance. Nature Genetics. 2007;39:574–575
  95. Vickers MH, Gluckman PD, Coveny AH, et al. Neonatal leptin treatment reverses developmental programming. Endocrinology. 2005;146:4211–4216

PII: S1521-690X(07)00064-4

doi: 10.1016/j.beem.2007.07.009

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 1 , Pages 1-16 , February 2008

Article Tools

* Image Usage & Resolution